The medical community is buzzing about the new drug, a dual-action treatment showing remarkable outcomes in preliminary studies . This innovative compound, a GLP-1 receptor agonist alongside a GIP agent , appears to effectively reduce body mass and positively affect metabolic function . Researchers are indicating that it has the potential to off… Read More